Literature DB >> 10030299

Microsporidia infection in transplant patients.

T Gumbo1, R E Hobbs, C Carlyn, G Hall, C M Isada.   

Abstract

BACKGROUND: Microsporidia are the most common cause of chronic diarrhea in patients infected with human immunodeficiency virus. Patients who have undergone organ transplantation may also be infected. The precise immune defect and the clinical picture in transplant patients have not been studied.
METHODS: We report a case of microsporidia infection in a heart transplant patient and review three other cases reported in the literature.
RESULTS: Infection in three solid organ transplant patients occurred when the patients were receiving immunosuppressive therapy for rejection 1.5-3 years after transplantation. Patients had chronic diarrhea, vomiting, dyspepsia, and weight loss for 1 month to 3 years.
CONCLUSIONS: Microsporidia may be the cause of chronic unexplained diarrhea and gastrointestinal disturbances in transplant patients. Defects in cell-mediated immunity probably play a role in maintaining the chronicity of this infection. Specific screening requests should be made to the microbiology laboratory when microsporidia infection is suspected.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10030299     DOI: 10.1097/00007890-199902150-00024

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  16 in total

Review 1.  Molecular diagnosis of an Enterocytozoon bieneusi human genotype C infection in a moderately immunosuppressed human immunodeficiency virus seronegative liver-transplant recipient with severe chronic diarrhea.

Authors:  A Sing; K Tybus; J Heesemann; A Mathis
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

2.  Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen.

Authors:  Christina M Coyle; Louis M Weiss; Luther V Rhodes; Ann Cali; Peter M Takvorian; Daniel F Brown; Govinda S Visvesvara; Lihua Xiao; Jaan Naktin; Eric Young; Marcelo Gareca; Georgia Colasante; Murray Wittner
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

Review 3.  The microsporidian polar tube: a highly specialised invasion organelle.

Authors:  Yanji Xu; Louis M Weiss
Journal:  Int J Parasitol       Date:  2005-08       Impact factor: 3.981

Review 4.  First cases of microsporidiosis in transplant recipients in Spain and review of the literature.

Authors:  A L Galván; A M Martín Sánchez; M A Pérez Valentín; N Henriques-Gil; F Izquierdo; S Fenoy; C del Aguila
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

5.  Real-time PCR method for detection of Encephalitozoon intestinalis from stool specimens.

Authors:  D M Wolk; S K Schneider; N L Wengenack; L M Sloan; J E Rosenblatt
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  MyD88-dependent pathway is essential for the innate immunity to Enterocytozoon bieneusi.

Authors:  Q Zhang; X Feng; W Nie; D T Golenbock; H Mayanja-Kizza; S Tzipori; H Feng
Journal:  Parasite Immunol       Date:  2011-04       Impact factor: 2.280

Review 7.  Zoonotic potential of the microsporidia.

Authors:  Alexander Mathis; Rainer Weber; Peter Deplazes
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

8.  Transmission of Enterocytozoon bieneusi between a child and guinea pigs.

Authors:  Vitaliano A Cama; Julie Pearson; Lilia Cabrera; Luz Pacheco; Robert Gilman; Sarah Meyer; Ynes Ortega; Lihua Xiao
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

Review 9.  Therapeutic targets for the treatment of microsporidiosis in humans.

Authors:  Bing Han; Louis M Weiss
Journal:  Expert Opin Ther Targets       Date:  2018-11-01       Impact factor: 6.902

10.  Induction of a rapid and strong antigen-specific intraepithelial lymphocyte response during oral Encephalitozoon cuniculi infection.

Authors:  Magali Moretto; Louis M Weiss; Imtiaz A Khan
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.